T 0977/93 (Canine coronavirus vaccine) of 30.3.1999

European Case Law Identifier: ECLI:EP:BA:1999:T097793.19990330
Date of decision: 30 March 1999
Case number: T 0977/93
Application number: 84902632.3
IPC class: A61K 39/12
Language of proceedings: EN
Distribution: A
Download and more information:
Decision text in EN (PDF, 44 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: OJ | Published
Title of application: Canine coronavirus vaccine
Applicant name: American Home Products Corporation
Opponent name: Rhone Merieux
Board: 3.3.04
Headnote: A product made available to the public is not reproducible within the meaning of decision G 0001/92 (point 4.1) and thus does not belong to the state of the art if the skilled person is not in a position to establish identity of the reproduced product with the commercially available product because the intrinsic and extrinsic features of the product are not accessible and there is a high probability of variation upon reproduction. (See points 11.1 to 11.3 and 12 of the "Reasons")
Relevant legal provisions:
European Patent Convention 1973 Art 123(2)
European Patent Convention 1973 Art 123(3)
European Patent Convention 1973 Art 54
European Patent Convention 1973 Art 56
Keywords: Availability of the intrinsic and extrinsic features of a vaccine (no)
Inventive step (yes)
Catchwords:

-

Cited decisions:
G 0002/88
G 0001/92
Citing decisions:
T 1076/00
T 1833/14

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t930977ex1.html

Date retrieved: 17 May 2021

10 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Offical Journal of the EPO

Case Law Book: I Patentability

Case Law of the Enlarged Board

General Case Law